Transgenic mice to study the role of dopamine receptors in cardiovascular function

Clinical and Experimental Hypertension

Volumn 19, Issue 1-2, 1997, Pages 15-25

  Jose, Pedro A ^a   Drago, John ^b   Accili, Domenico ^c   Eisner, Gilbert M ^d   Felder, Robin A ^e  

^a Children's Medical Center   (United States)

^b MONASH UNIVERSITY   (Australia)

^c National Institute of Digestive and Diabetes and Kidney Diseases   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

dopamine receptor subtypes; hypertension; sodium excretion; transgenic animals

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 3 RECEPTOR;

ANIMAL EXPERIMENT; CARDIOVASCULAR FUNCTION; CONFERENCE PAPER; GLOMERULUS FILTRATION RATE; HETEROZYGOSITY; HYPERTENSION; MOUSE; NONHUMAN; SODIUM EXCRETION; TRANSGENIC MOUSE;

EID: 0031056768     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969709080801     Document Type: Conference Paper

References (61)

1. Jose, P.A., Eisner, G.M., Drago, J., Carey, R.M., Felder, R.A. Dopamine receptor signaling defects in spontaneous hypertension. Am J Hypertens. 1996; 9: 400-405.
2. Jose, P.A., Raymond, J.R., Bates, M.D., Aperia, A., Felder, R.A., Carey, R.M. The renal dopamine receptors. J Am Soc Nephrol. 1992; 2: 1265-1278.
3. Ball, S.G., Lee, M.R. The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone? Br J Clin Pharmacol. 1977; 4: 115-119.
4. Hegde, S.S., Jadhav, A.L., Lokhandwala, M.F. Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension. 1989; 13: 828-834.
5. Siragy, H.M., Felder, R.A., Howell, N.L., Chevalier, R.L., Peach, M.J., Carey, R.M. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol. 1989; 257: F469-F477.
6. Hansell, P., Fasching, A. The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia. Kidney Int. 1981; 39: 253-258.
7. Mülhlbauer, B., and H. Osswald. Urinary dopamine excretion in conscious rats: effects of carbidopa in different states of sodium balance. Renal Physiol. Biochem. 16: 117-124, 1993.
8. Pelayo, J.C., Fildes, R.D., Eisner, G.M., Jose, P.A. Effects of dopamine blockade on renal sodium excretion. Am J Physiol. 1983; 245: F247-F253, 1983.
9. Goldstein, D.S., Stull, R., Eisenhofer, G., Gill, J.R. Jr. Urinary excretion of dihydroxy-phenylalanine and dopamine during alterations of dietary salt intake in humans. Clin Sci. 1989; 76: 517-522.
10. +ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am J Physiol. 1988; 254: F795-F801.
11. Felder, R.A., Seikaly, M.G., Cody, P., Eisner, G.M., Jose, P.A. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension. 1990; 15: 560-569.
12. +-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension. 1993: 21: 767-771.
13. Debska-Slizien, A., Ho, P., Drangova, R., Baines, A.D. Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. J Am Soc Nephrol. 1994; 5: 1125-1132.
14. Chen, C.J., Beach, R.E., Lokhandwala, M.F. Dopamine fails to inhibit renal tubular sodium pump in spontaneously hypertensive rats. Hypertension 1993; 21: 364-372.
15. + exchanger in spontaneously hypertensive rats. Am J Physiol. 1991; 261: F526-F536.
16. +-ATPase by G proteins in spontaneously hypertensive rats. Am J Physiol. 1994; 267: F1069-F1075.
17. Kinoshita S, Sidhu A, Felder RA: Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989; 84: 1849-1856.
18. Felder, R.A., Kinoshita, S., Ohbu, K., Mouradian, M.M., Sibley, D.R., Monsma, F.J. Jr., Minowa, T., Minowa, M.T., Canessa, L.M., Jose, P.A. Renal dopamine-1 receptor mRNA and organ specificity of the dopamine-1 receptor/adenylyl cyclase coupling defect in the spontaneously hypertensive rat. Am J Physiol. 1993; 264: R726-R732.
19. Horiuchi, A., Albrecht, F., Eisner, G.M., Jose, P.A., Felder, R.A. Renal dopamine receptors and pre- and post-cAMP mediated sodium transport defect in the spontaneously hypertensive rat. Am J Physiol. 1992; 263: F1105-F1111.
20. Chen, C.J., Vyas, S.J., Eichberg, J., Lokhandwala, M.F. Diminished phospholipase C activation by dopamine in spontaneously hypertensive rats. Hypertension. 1992; 19: 102-108.
21. Chatziantoniou, C., Ruan, X., Arendshorst, W.J. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Nad Acad Sci USA. 1995; 92: 2924-2928.
22. Racz, K., Kuchel, O., Buu, N.T., Tenneson, S. Peripheral dopamine synthesis and metabolism in spontaneously hypertensive rats. Circ Res. 1986; 57: 889-897.
23. Albrecht F.E., Robillard, I.E., Eisner, G.M., Jose, P.A. Receptor and G-protein regulation of the renal apical sodium/hydrogen exchanger (NHE) in genetic hypertension. Pediatr Res. 1995; 37: 358A (Abstract).
24. Shigetomi, S., Ueno, S., Kono, H., Tosaki, H., Suenaga, K., Hashimoto, S., Fukuchi, S. Role of dopamine receptor in the pathogenesis of hypertension after sodium loading. Folia Endocrinol. 1986; 62: 26-33.
25. Yoshimura, M., Kambara, S., Takahashi, H., Okabayashi, H., Ijichi, H. Involvement of dopamine in the development of hypertension in spontaneously hypertensive rats; effect of carbidopa, inhibitor of peripheral dopa decarboxylase. Clin Exp Hypertens. 1987; A: 1585-1599.
26. 1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest. 1996; 97: 2283-2288.
27. 1B dopamine receptors in rat kidney. Soc Neurosci Abstracts, Washington, DC, 1993, p75.
28. Matsushima, Y., Kawamura, M., Akabane, S., Imanishi, M., Kuramochi, M., Ito, K., Omae, T. Increases in angiotensin II content and tubular angiotensin II receptors in pre-hypertensive spontaneously hypertensive rat. J Hypertens. 1988; 6: 791-796.
29. Thomas, D., Harris, P.J., Morgan, T.O. Age-related changes in angiotensin II-stimulated proximal tubule fluid reabsorption in the spontaneously hypertensive rat. J Hypertens 1988; 6: (suppl 4)S449-S451.
30. 1R) receptor expression in the proximal tubule. J Am Soc Nephrol. 1995; 6: 734 (Abstract).
31. Siragy, H.M., Felder, R.A., Howell, N.L., Chevalier, N.L., Peach, M.J., Carey, R.M. Evidence that dopamine-2 mechanisms control renal function. Am J Physiol. 1990; 259: F793-F800.
32. 2 receptors. Am J Physiol. 1990; 259: F924-F928.
33. 2. J Clin Invest. 1992; 89: 1496-1500.
34. Sheikh-Hamad, D., Wang, Y.P., Jo, O.D., Yanagawa, N. Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane. Am J Physiol. 1993; 264: F737-F743.
35. Oparil, S., Chen, Y-F., Berecek, K.H., Calhoun, D.A., Wyss, J.M. The role of the central nervous system in hypertension, in: Hypertension, Pathophysiology, Diagnosis, and Management, Laragh, J.H., Brenner, B.M., eds., 2nd edition, Raven Press, NY 1995, p713-740.
36. Koepke, J.P., Kopp, U.C., DiBona, G.F. The kidney in the pathogenesis of hypertension: role of the renal nerves. in: The Kidney in Hypertension, Kaplan, N.M., Brenner, B.M., Laragh, J.H., eds., Raven Press, NY, 1987, p53-65.
37. Essler, M., Ferrier, C., Lambert, G., Eisenhofer, G., Cox, H., Jennings, G. Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension. 1991; 17[supplII]: III-29-III-35.
38. Lundin, S., Ricksten, S.E., Thoren, P. Renal sympathetic activity in spontaneously hyper-tensive rats and normotensive controls, studied by three different methods. Acta Physiol Scand. 1984; 120: 265-272.
39. Petrovic, T., Bell, C. Catecholamines in kidneys of normotensive and genetically hypertensive rats. Effects of salt load. Hypertension. 1986, 8: 122-127.
40. Adams, M.A., Bobik, A., Korner, PI. Differential development of vascular and cardiac hypertrophy in genetic hypertension. Relation to sympathetic function. Hypertension. 1989; 14: 191-202.
41. Yoshida, M., Yoshida, W., Satoh, S. Effect of renal denervation on tissue catecholamine content in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1995; 22: 512-517.
42. Cooper, J.R., Bloom, FE, Roth, R.H. The Biochemical Basis of Neuropharmacology. 6th ed, Oxford University Press, NY, 1991.
43. Rump, L.C., Schollmeyer, P. J. Dopamine modulation of neurotransmission in rat and human kidney. in: Cardiovascular and Renal Actions of Dopamine, Soares-Da-Silva, P., ed., Pergamon Press, Oxford, England, 1993, p91-98.
44. Bohmann, C., Rump, L.C., Schaible, U., von Kugelgen, I. Alpha-adrenoceptor modulation of norepinephrine and ATP release in isolated kidneys of spontaneously hypertensive rats. Hypertension. 1995; 25: 1224-1231.
45. Bohmann, C., Schaible, U., Schollmeyer, P., Rump, L.C. Alpha2D-adrenoceptors modulate renal noradrenaline release in normotensive and spontaneously hypertensive rats. Eur J Pharmacol. 1994; 271: 283-292.
46. Tsuda, K., Tsuda, S., Masuyama, Y. The role of dopamine in the regulation of neuro-transmitter release in spontaneously hypertensive rats. Jpn Heart J. 1988; 29: 215-222.
47. Goldberg, L.I., Kohli, I.D., Glock, D. Conclusive evidence for two subtypes of peripheral dopamine receptors. in: Dopaminergic Systems and Their Regulation, Woodruff, G.N., Poat, J.A., Roberts, P.J., eds., Macmillan, London, 1986, p195-212.
48. Lokhandwala, M.F., Steenberg, M.L. Selective activation by LY-141865 and apomor-phine of presynaptic dopamine receptors in the rat kidney and influence of stimulation of parameters in the action of dopamine. J Pharmacol Exp Ther. 1984; 228: 161-167.
49. 3) as a target for neuroleptics. Nature (Lond) 1990; 347: 146-151.
50. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J Pharmacol Exp Ther. 1995; 275: 899-913.
51. Mierau, J., Schneider, F.J., Ensinger, H.A., Chio, C.L., Lajiness, M.E., Huff, R.M. Pramipexole binding and activation of clone and expressed D2, D3 and D4 receptors. Eur J Pharmacol. 1995; 290: 29-36.
52. 2 subfamily of dopamine receptor genes in the kidney. Am J Physiol. 1994; 266: F646-F650.
53. O'Malley, K.L., Harmon, S., Tang, L., Han, S., Todd, R.D. The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol. 1992; 4: 137-146.
54. Henrich, W.L., Levi, M. Ontogeny of renal renin release in spontaneously hypertensive rat and Wistar-Kyoto rat. Am J Physiol. 1991; 260: F530-F535.
55. Yao, L., Yamaguchi, I., Ozono, R., Walk, S.F., McGrath, B., Dagli, H., Carey, R.M., Jose, P.A., Felder, R.A. Dopamine receptor (DAR) subtype expression and function in rat juxtaglomerular (JG) cells. Pediatr Res. 1996; 39: 372A.
56. Worth, D.P., Harvey, J.N., Brown, J., Worral, A., Lee, M.R. Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous y-L-glutamyl-L-dopa. Br J Clin Pharmacol. 1986; 21: 497-502.
57. MacDonald, T.M., Jeffrey, R.F., Freestone, S., Lee, M.R. (+)-sulpiride antagonizes the renal effects of gamma-L-glutamyl-L-dopa in man. Br J Clin Pharmacol. 1988; 25:203-212.
58. Jeffrey, R.F., MacDonald, T.M., Marwick, K., Lee, M.R. The effect of carbidopa and indomethacin on the renal response to Y-L-glutamyl-L-dopa in normal man. Br J Clin Phannacol. 1988; 25:195-201.
59. Sanada, H., Yao, L., Yamaguchi, I., Mouradian, M.M., Carey, R.M., Jose, P.A., Felder, R.A. Dopamine receptor subtype regulation of renin secretion in rat juxtaglomerular cells. (submitted Am Soc Nephrol Meet, 1996).
60. 3 dopamine receptors. J Invest Med. 1996; 44: 307A.
61. 1A dopamine receptors. Proc Natl Acad Sci USA 1994; 91: 12564-12568.